当前位置：
X-MOL 学术
›
Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation
Clinical Immunology ( IF 4.5 ) Pub Date : 2020-11-28 , DOI: 10.1016/j.clim.2020.108639 Christine Wildermann 1 , Mohammed Alosaimi 2 , Sophie Liebenehm 1 , Eva-Maria Jacobsen 1 , Thomas F E Barth 3 , Peter Möller 3 , Klaus-Michael Debatin 1 , Ansgar Schulz 1 , Mehtap Sirin 1 , Ibraheem F Abosoudah 4 , Fowzan S Alkuraya 5 , Raif S Geha 6 , Manfred Hönig 1
中文翻译：
4-1BB缺陷型EBV诱导的淋巴组织增生患者成功进行造血干细胞移植
更新日期：2020-12-04
Clinical Immunology ( IF 4.5 ) Pub Date : 2020-11-28 , DOI: 10.1016/j.clim.2020.108639 Christine Wildermann 1 , Mohammed Alosaimi 2 , Sophie Liebenehm 1 , Eva-Maria Jacobsen 1 , Thomas F E Barth 3 , Peter Möller 3 , Klaus-Michael Debatin 1 , Ansgar Schulz 1 , Mehtap Sirin 1 , Ibraheem F Abosoudah 4 , Fowzan S Alkuraya 5 , Raif S Geha 6 , Manfred Hönig 1
Affiliation
Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.
中文翻译：
4-1BB缺陷型EBV诱导的淋巴组织增生患者成功进行造血干细胞移植
在患有最近描述的影响 T 细胞共激活分子 4-1BB 的免疫缺陷的患者中，在 HSCT 之前不需要完全缓解复发性EBV阳性淋巴瘤以获得长期治愈。
京公网安备 11010802027423号